PRELUDE CAPITAL MANAGEMENT, LLC - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 268 filers reported holding IMMUNOGEN INC in Q2 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.4%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2023$1,607,869
+11.6%
101,315
+32.6%
0.10%
+11.7%
Q2 2023$1,441,328
+20490.4%
76,382
+2305.7%
0.09%
Q2 2019$7,000
+250.0%
3,175
+353.6%
0.00%
Q1 2019$2,000
-91.3%
700
-68.2%
0.00%
-100.0%
Q1 2018$23,000
-32.4%
2,200
-51.1%
0.00%
-33.3%
Q3 2017$34,0000.0%4,500
-64.6%
0.00%
-25.0%
Q3 2016$34,000
+100.0%
12,700
+124.8%
0.00%
+100.0%
Q2 2016$17,000
-79.5%
5,650
-42.3%
0.00%
-83.3%
Q1 2016$83,000
+15.3%
9,800
+84.9%
0.01%
+9.1%
Q4 2015$72,000
+41.2%
5,3000.0%0.01%
+57.1%
Q3 2015$51,000
-40.0%
5,300
-10.2%
0.01%
-41.7%
Q2 2015$85,000
+46.6%
5,900
-9.2%
0.01%
+50.0%
Q1 2015$58,000
-34.1%
6,500
-55.2%
0.01%
-38.5%
Q4 2014$88,000
-84.8%
14,500
-62.7%
0.01%
-83.3%
Q1 2014$580,000
+200.5%
38,823
+195.3%
0.08%
+143.8%
Q4 2013$193,000
-13.8%
13,1480.0%0.03%
-11.1%
Q3 2013$224,000
-59.0%
13,148
-60.2%
0.04%
-69.2%
Q2 2013$547,00033,0000.12%
Other shareholders
IMMUNOGEN INC shareholders Q2 2023
NameSharesValueWeighting ↓
Redmile Group, LLC 17,503,417$277,779,22813.22%
Fairmount Funds Management LLC 5,929,592$94,102,62511.32%
CM Management, LLC 500,000$7,935,0008.42%
SILVERARC CAPITAL MANAGEMENT, LLC 1,307,435$20,748,9936.29%
Altium Capital Management LP 725,000$11,505,7506.00%
RA Capital Management 13,322,288$211,424,7114.16%
TANG CAPITAL MANAGEMENT LLC 1,500,000$23,805,0003.36%
BRIDGER MANAGEMENT, LLC 467,220$7,414,7812.73%
Birchview Capital, LP 190,000$3,015,3002.57%
Boxer Capital, LLC 2,961,000$46,991,0702.50%
View complete list of IMMUNOGEN INC shareholders